English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
2025 News Releases
- March 10, 2025 - Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
- January 25, 2025 - Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer's Disease Blood Test
- January 15, 2025 - Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
2024 News Releases
- Sept 17, 2024 - Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
- July 30, 2024 - Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
- July 24, 2024 - Beckman Coulter’s DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.’s Annual Supplier Innovation Celebration
- May 29, 2024 - Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
- May 7, 2024 - Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
- April 16, 2024 - Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
- March 11, 2024 - Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly Blood-based Neurodegenerative Disease Diagnostics
- February 6, 2024 - Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President
- January 30, 2024 - Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
2023 News Releases
- July 25, 2023 - Beckman Coulter’s DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
- July 25, 2023 - Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
- July 19, 2023 - Beckman Coulter Connects Scopio Labs Digital Cell Morphology with Hematology Workcell Extending Automated Workflow
- July 17, 2023 - Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test
- May 15, 2023 - Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
- January 31, 2023 - Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections
2022 News Releases
- October 11, 2022 - Beckman Coulter Acquires Artificial Intelligence Company Providing Evidence-Based Clinical Decision Support for Emergency Departments
- July 25, 2022 - Beckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments
- July 20, 2022 - Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform
- May 31, 2022 - Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis
- March 15, 2022 - Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions
2021 News Releases
- July 26, 2021 - Beckman Coulter to Distribute BNP Cardiac Assay to Customers
- May 4, 2021 - Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
- March 23, 2021 - Beckman Coulter’s SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
- March 18, 2021 - Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 Testing
- January 25, 2021 - Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs
2020 News Releases
- December 18, 2020 - Beckman Coulter launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
- November 23, 2020 - Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
- November 10, 2020 - Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs
- October 15, 2020 - Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C)
- October 09, 2020 - Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
- October 06, 2020 - Beckman Coulter completes first in a series of antibody neutralization studies
- October 01, 2020 - FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
- August 24, 2020 - Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs
- August 5, 2020 - Study shows patients with abnormal values of Beckman Coulter’s novel MDW biomarker are four- to six- times more likely to be diagnosed with (or develop) sepsis
- July 22, 2020 - Beckman Coulter’s Automated Blood Banking Analyzer Receives 510(k) FDA Clearance
- July 21, 2020 - Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year
- July 17, 2020 - Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards
- July 06, 2020 - Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City
- June 29, 2020 - Beckman Coulter’s SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization
- June 15, 2020 - Beckman Coulter’s SARS-CoV-2 IgG antibody test now available in markets accepting the CE Mark
- May 18, 2020 - Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market
- May 15, 2020 - Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients
- April 22, 2020 - Beckman Coulter announces May launch of its SARS-CoV-2 serology test and ramps production to deliver over 30 million tests per month
- March 31, 2020 - Beckman Coulter announces development of tests to detect coronavirus antibodies
- January 28 2020 - Beckman Coulter’s Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
- January 7, 2020 - Beckman Coulter announces installation of DxH 900 and Early Sepsis Indicator at award-winning NHS pathology partnership
2019 News Releases
- October 29 2019 - Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
- October 21, 2019 - Mid-size suv laboratories can now enjoy the same efficiency benefits as large facilities with Beckman Coulter's new hematology analyzer
- October 9, 2019 - Beckman Coulter’s DxA 5000 total laboratory automation solution receives U.S. FDA 510(k) clearance
- August 6, 2019 - Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row
- August 1, 2019 - Laboratories of all Sizes Can Now Harness the Power of Automation with Beckman Coulter
- May 2, 2019 - Beckman Coulter Introduces Total Laboratory Automation Solution That Sets New Standard for Turnaround Time
- April 18, 2019 - Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration
- March 26, 2019 - Beckman Coulter’s New Procalcitonin Assay Helps Physicians Accurately Identify Patients at Risk for Progression to Septic Shock
- March 21, 2019 - Beckman Coulter’s Compact, Low-volume Hematology Analyzer Receives FDA 510(k) Clearance
- March 7, 2019 - Beckman Coulter’s HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes
2018 Press Releases
- December 19, 2018 - Beckman Coulter’s New DxONE Workflow Manager Enables Low-volume Laboratories to Improve Turnaround Time and Maximize Staff Efficiency
- December 3, 2018 - Beckman Coulter Diagnostics Joins with Sepsis Alliance to Help Improve Sepsis Patient Outcomes
- November 27, 2018 - Beckman Coulter’s New DxONE Inventory Manager Helps Laboratory Professionals Save Time and Money
- October 16, 2018 - Beckman Coulter Diagnostics Joins Forces with Johns Hopkins Medicine in Healthcare Innovation Initiative
- September 10, 2018 - Beckman Coulter Announces Release of Latest Innovations to Middleware Software
- September 4, 2018 - Beckman Coulter Sponsors 2nd World Sepsis Conference
- August 1, 2018 - Beckman Coulter Announces Commercialization of DxM MicroScan WalkAway System
- July 27, 2018 - Beckman Coulter and U.S. ARKRAY, Inc., Announce Partnership and Launch of the iQ Workcell to Deliver Scalable, Harmonized Solutions in the United States
- July 23, 2018 - Beckman Coulter Diagnostics Brings Clinical Innovations to 70th AACC Annual Meeting and Clinical Laboratory Expo
- July 19, 2018 - Beckman Coulter Announces Launch of DxONE PROService in Europe
- June 27, 2018 - Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High-sensitivity Access hsTnI Assay
- June 26, 2018 - Beckman Coulter Diagnostics Receives Health Canada Clearance for Access hsTnI, its New High Sensitivity Troponin Assay
- June 25, 2018 - Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
- June 21, 2018 - UCI, Beckman Coulter Diagnostics announce strategic collaboration
- June 20, 2018 - Health Canada Licenses Beckman Coulter’s Access Sensitive Estradiol Assay
- June 19, 2018 - Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males
- May 10, 2018 - Beckman Coulter Diagnostics Launches New Hematology Analyzer Software to Help Laboratories Deliver Quality Results with Greater Productivity
- May 3, 2018 Beckman Coulter Achieves CE Mark for Its Early Sepsis Indicator*
- May 1, 2018 - Beckman Coulter Launches the DxH 900 Hematology Analyzer
- April 18, 2018 - Beckman Coulter Diagnostics Announces CE Mark of the DxH 520* Closed Tube, 5-part Differential Hematology Analyzer for Small-volume Labs
- April 17, 2018 - Beckman Coulter Sponsors Top-ranked Sepsis Clinical Guide App to Empower Clinicians Caring for Patients in Acute Settings
- April 10, 2018 - Beckman Coulter Diagnostics Announces Worldwide Commercialization of the Access Sensitive Estradiol
- March 15, 2018 - Technopath Clinical Diagnostics and Beckman Coulter Diagnostics Enter Global Distribution Agreement
- February 20, 2018 - Beckman Coulter Diagnostics in Partnership with NTE-SENER Announces European Launch of DxM 6100 Autoplak Advanced System
- January 4, 2018 - Beckman Coulter Diagnostics Adds 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) Assays to Comprehensive Chemistry Test Menu
2017 News Releases
- December 21, 2017 - Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay
- November 27, 2017 - Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly
- November 21, 2017 - Recently published study reports a significant reduction in biopsy procedures performed when Prostate Health Index (phi) testing is used by physicians in routine clinical practice
- November 7, 2017 - Beckman Coulter Diagnostics Receives CE Mark Clearance for its High-sensitivity Access hsTnI Assay
- August 10, 2017 - Beckman Coulter Diagnostics Announces Enhancements to the Access 2 Immunoassay System
- July 27, 2017 - Beckman Coulter Diagnostics Introduces DxONE™ Clinical Information Management Tools
- July 20, 2017 - Partnering Today for a Stronger Tomorrow: Beckman Coulter Showcases Solutions for Navigating the Changing Healthcare Landscape
- June 21, 2017 - Beckman Coulter Diagnostics Expands Chemistry Menu to include FDA-cleared Procalcitonin (PCT)
- June 12, 2017 - The future of laboratory services revealed at EuroMedLab 2017: The Beckman Coulter Diagnostics Difference
- April 20, 2017 - Beckman Coulter Diagnostics Receives CE Mark and Expands Chemistry Menu to include Procalcitonin (PCT)
2016 News Releases
- December 16, 2016 - Henry Ford Health System Enhances Patient Care through Laboratory Automation Partnership
- October 21, 2016 - Grady Health System Improves Patient Care with Enhanced Laboratory Services through Beckman Coulter Partnership
- October 17, 2016 - FDA Clears Commercial Release of Access TSH (3rd IS) Assay for Beckman Coulter Immunoassay Systems
- October 13, 2016 - Laboratory of the Year Award Winner PCL Alverno to Highlight Partnership with Beckman Coulter Diagnostics as Key Component of their Success at Upcoming Lab Quality Confab
- August 30, 2016 - DiaSorin and Beckman Coulter Form Strategic Partnership to Bring the Liaison XL Hepatitis and HIV Products to the U.S. Market
- August 3, 2016 - Beckman Coulter and Augusta University’s Medical Center Sign Fifteen Year Agreement Collaborating on Innovative Methods to Improve Patient Outcomes
- August 2, 2016 - Advancing Patient Care through Laboratory Excellence: Beckman Coulter Showcases Integrated Product-Service Solutions at 2016 AACC Annual Scientific Meeting and Clinical Lab Expo
- June 23, 2016 - Beckman Coulter introduces Sentinel Pancreatic Amylase reagent and calibrator on AU Clinical Chemistry Analyzers
- June 8, 2016 - Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs
- May 6, 2016 - Beckman Coulter Features Prostate Health Index (phi) at 2016 AUA Annual Meeting
2015 News Releases
- August 31, 2015 - Beckman Coulter Diagnostics Receives 2015 Scientists’ Choice Award for Best New Clinical Laboratory Product
- July 24, 2015 - Beckman Coulter Diagnostics Demonstrates Solutions to Balance Better Care and Efficiency at the 2015 AACC Annual Meeting and Clinical Lab Expo
- July 20, 2015 - DiaSorin Sign a Distribution Partnership for Hepatitis and HIV Tests in China
- June 15, 2015 - Beckman Coulter Brings New Thinking to New Lab Challenges at EuroMedLab 2015
- April 20, 2015 - Bio-Rad Grants Exclusive Distribution Rights for Access HIV and Hepatitis C Assays
